Document is current
Any future updates will be listed below
-
Authors
Ranada, Shaun I.
Lei, Lucy Y.
Baker, Jacquie
Wilson, Richard
Phillips, Aaron A.
Sheldon, Robert S.
Raj, Satish R. https://orcid.org/0000-0002-5890-3785
-
Funding
Funding for this research was provided by:
National Center for Advancing Translational Sciences (ULI TR000445)
Natural Sciences and Engineering Research Council of Canada (NSERC) Brain CREATE Program
Alberta Graduate Excellence Scholarship
Alberta Strategy for Patient Oriented SUPPORT Unit
Libin Cardiovascular Institute
Canadian Institutes of Health Research (CIHR) Fellowship
Libin Cardiovascular Institute Post-Doctoral Fellowship in Women’s Cardiovascular Health
- License Information
-
More Information
Article History
Received: 13 November 2022
Accepted: 20 January 2023
First Online: 27 January 2023
Declarations
:
: The authors declare that they have no conflict of interest. SIR: none, LYL: none, JB: none, RW: none, AP: is a consultant for and shareholder of ONWARD Medical—a publicly traded company commercializing hemodynamic therapeutics for neurological conditions. Honoraria from AD Instruments. RSS: none. SRR: Served as a consultant for Lundbeck LLC, Theravance Biopharma, and Amneal Pharma related to neurogenic orthostatic hypotension; Consultant to Servier Affaires Medicales, Regeneron, and argenx BV related to postural orthostatic tachycardia syndrome. Honoraria from Spire Learning and Medscape for developing CME materials on neurogenic orthostatic hypotension. DMSB Chair for a Phase 2 study of an irritable bowel syndrome medication for Arena Pharmaceuticals with compensation. Past-President of the American Autonomic Society without financial compensation.
: The manuscript does not contain clinical studies or patient data.
